Improved clinical efficacy of external cardioversion by fluoroscopic electrode positioning and comparison to internal cardioversion in patients with atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 1 II, 1999, Pages 233-237

  Mehdirad, Ali A ^a,b   Clem, Kelley L ^a   Love, Charles J ^a   Nelson, Steven D ^a   Schaal, Stephen F ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Atrial fibrillation; External cardioversion; Internal cardioversion; Optimized external cardioversion

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; ELECTRODE; FEMALE; FLUOROSCOPY; HEART ATRIUM FIBRILLATION; HUMAN; MALE; SAFETY;

ADOLESCENT; ADULT; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; HEART ATRIA; HEART CATHETERIZATION; HEART RATE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 0032924804     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00339.x     Document Type: Article

References (13)

1. Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias: Use of synchronized capacitor discharge. JAMA 1962; 182:548-555.
2. Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967; 29:469-489.
3. DeSilva RA, Grayboys TTS, Podrid PJ, et al. Cardioversion and defibrillation. Am Heart J 1980; 100:881-895.
4. Mancini J, Goldberger AI. Cardioversion for atrial fibrillation: Consideration of embolization, anticoagulation, prophylactic pacemaker and long term success. Am Heart J 1982; 104: 617-621.
5. Benditt D, Benson DW Jr., Dunningan A, et al. Atrial flutter, atrial fibrillation and other primary atrial tachycardias. Med Clin North Am 1984; 68:895-918.
6. Levy S, Lauribe P, Dolla E, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992; 86:1415-1420.
7. Murgatroyd FD, Slade AKB, Sopher M, et al. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995; 25:1347-1353.
8. Lok NS, Lau CP. Effect of sotalol on transvenous atrial defibrillation for acute and chronic atrial fibrillation (abstract). J Am Coll Cardiol 1995; 25:109A.
9. Lok N-S, Lau C-P, Ho D S-W, et al. Hemodynamic effects and clinical determinants of defibrillation threshold for transvenous atrial defibrillation using biphasic shocks in patients with chronic atrial fibrillation. PACE 1997; 20(Pt. I):899-908.
10. Cooper RAS, Alfreness CA, Smith WM, et al. Internal cardioversion of atrial fibrillation in sheep. Circulation 1993; 87-1673-1686.
11. Lok N-S, Lau C-P, Tse H-F, et al. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. JACC 1997; 30: 1324-1330.
12. Ayers GM, Ilina MI, Wagner DJ, et al. Cardiac vein electrode locations for transvenous atrial defibrillation. JACC 1993; 21:306A.
13. Kerber R, Grayzel J, Hoyt R, et al. Transthoracic resistance in human defibrillation. Circulation 1982; 63:676-682.